4//SEC Filing
Adamas Pharmaceuticals Inc 4
Accession 0001209191-16-145419
CIK 0001328143operating
Filed
Oct 6, 8:00 PM ET
Accepted
Oct 7, 5:07 PM ET
Size
18.3 KB
Accession
0001209191-16-145419
Insider Transaction Report
Form 4
Went Gregory T
DirectorChief Executive Officer10% Owner
Transactions
- Other
Common Stock
2016-10-05−117,450→ 146,208 total - Other
Stock Option (Right to Buy)
2016-10-05−121,784→ 128,216 totalExercise: $0.67Exp: 2021-11-16→ Common Stock (121,784 underlying) - Other
Stock Option (Right to Buy)
2016-10-05−27,995→ 32,005 totalExercise: $0.67Exp: 2022-02-22→ Common Stock (27,995 underlying) - Other
Stock Option (Right to Buy)
2016-10-05−262,963→ 605,037 totalExercise: $8.99Exp: 2024-02-20→ Common Stock (262,963 underlying) - Other
Stock Option (Right to Buy)
2016-10-05−9,439→ 65,561 totalExercise: $17.31Exp: 2025-02-24→ Common Stock (9,439 underlying) - Other
Common Stock
2016-10-05−195,400→ 195,392 total(indirect: By Trust)
Holdings
- 80,000(indirect: By Trust)
Common Stock
- 80,000(indirect: By Trust)
Common Stock
Footnotes (5)
- [F1]Securities disposed of pursuant to a marital separation agreement.
- [F2]Fully vested.
- [F3]The Option shares vest as follows: one-fifth (1/5th) of the shares vested one year after February 1, 2012; the balance of the shares vest in a series of forty-eight (48) successive equal monthly installments measured from the first anniversary of February 1, 2012, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2007 Stock Plan) as of each such date. The Option shares are subject to an early exercise right and may be exercised in full prior to vesting.
- [F4]The Option shares vest as follows: one-fifth (1/5th) of the shares vest one year after February 20, 2014; the balance of the shares vest in a series of forty-eight (48) successive equal monthly installments measured from the first anniversary of February 20, 2014, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2007 Stock Plan) as of each such date. The Option shares are subject to an early exercise right and may be exercised in full prior to vesting.
- [F5]The Option vests as follows: 1/48th of the option shares vest on the 1st of each month beginning with March 1, 2015, subject to Reporting Person's Continuous Service (as defined in the Issuer's 2014 Equity Incentive Plan) as of each such date.
Documents
Issuer
Adamas Pharmaceuticals Inc
CIK 0001328143
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001328143
Filing Metadata
- Form type
- 4
- Filed
- Oct 6, 8:00 PM ET
- Accepted
- Oct 7, 5:07 PM ET
- Size
- 18.3 KB